Cargando…
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
Wild-type reovirus serotype 3 Dearing (T3wt), a non-pathogenic intestinal virus, has shown promise as a cancer therapy in clinical trials, but it would benefit from an increased potency. Given that T3wt is naturally adapted to the intestinal environment (rather than tumors), we genetically modified...
Autores principales: | Cristi, Francisca, Walters, Maiah, Narayan, Nashae, Agopsowicz, Kate, Hitt, Mary M., Shmulevitz, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685048/ https://www.ncbi.nlm.nih.gov/pubmed/38033400 http://dx.doi.org/10.1016/j.omto.2023.100743 |
Ejemplares similares
-
Genetic Modifications That Expand Oncolytic Virus Potency
por: Cristi, Francisca, et al.
Publicado: (2022) -
Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015) -
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants
por: Mohamed, Adil, et al.
Publicado: (2015) -
Novel High-throughput Approach for Purification of Infectious Virions
por: James, Kevin T., et al.
Publicado: (2016) -
Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020)